KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) Shares Outstanding (Weighted Average) (2016 - 2026)

National Health Investors filings provide 18 years of Shares Outstanding (Weighted Average) readings, the most recent being $48.3 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 5.69% to $48.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $48.3 million, a 5.69% increase, with the full-year FY2025 number at $46.9 million, up 6.91% from a year prior.
  • Shares Outstanding (Weighted Average) hit $48.3 million in Q1 2026 for National Health Investors, up from $46.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $48.3 million in Q1 2026 to a low of $43.4 million in Q1 2023.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $44.3 million (2022), compared with a mean of $44.9 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): dropped 5.37% in 2023 and later rose 9.1% in 2025.
  • National Health Investors' Shares Outstanding (Weighted Average) stood at $44.8 million in 2022, then fell by 3.1% to $43.4 million in 2023, then increased by 1.05% to $43.8 million in 2024, then grew by 6.91% to $46.9 million in 2025, then rose by 3.09% to $48.3 million in 2026.
  • The last three reported values for Shares Outstanding (Weighted Average) were $48.3 million (Q1 2026), $46.9 million (Q4 2025), and $47.4 million (Q3 2025) per Business Quant data.